Prostate cancer is the most common non-skin cancer in men. While some specialty organizations recommend that screening begin at age 40, there is little evidence showing real benefits to screening at this age.

After prostate cancer patients receive treatment, they still run the risk of the disease coming back. A newly approved imaging agent offers a way to detect recurrence earlier.

Prostate cancer surgery patients commonly experience erectile dysfunction. While many seek therapy to regain function, they may need more partner support to stay with the program.

Although most men who have their prostate removed to treat prostate cancer stay disease free, some have a recurrence. Radiation following the surgery appears to reduce the chance of the cancer returning.

To determine treatment for prostate cancer, doctors may look to a patient’s DNA. How aggressive the disease will be may be predicted by examining gene patterns in blood cells.

For 23 years, the third week in September has been designated “Prostate Cancer Awareness Week.” That’s when the Prostate Conditions Education Council ( PCEC ) was founded to give men access to free or low-cost prostate health screenings.

Several years ago, the United States Preventive Services Task Force (USPSTF) recommended against men over the age of 75 having prostate cancer screenings using the PSA (prostate-specific antigen) test.

Being diagnosed with any cancer makes you think about your life - and death. The course of prostate cancer, though, may be changing.

Prostate cancer screening guidelines have been changing over the past several years. All of this is thanks to the advice of United States Preventative Services Task Force (USPSTF). 

If you've been following the news about prostate cancer, you know a great deal of caution has been injected into the conversation. A new study shows that a conservative approach to the disease is quite valid.